AOC 1001 (del-desiran) — catalyst calendar
Upcoming
| Date | Event | Company | Drug | Official source & verification |
|---|---|---|---|---|
| 2026-08 (month) in 1mo
ESTIMATED |
READOUT
Global Study of Del-desiran for the Treatment of DM1
Phase 3 · DM1, Myotonic Dystrophy |
Avidity Biosciences, Inc. | AOC 1001 (del-desiran) |
ClinicalTrials.gov ↗
✓ Source-checked 2026-06-22
Sponsor-projected date — can change
|